spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR013201 Proteinase inhibitor I29, cathepsin propeptide

Protein matchesHelp
UniProtKB
Matches:
2244 proteins
AccessionHelp IPR013201 Prot_inhib_I29
TypeHelp Domain
SignaturesHelp
InterPro RelationshipsHelp
Found in IPR013128 Peptidase C1A, papain
IPR015644 Peptidase C1A, cathepsin K
IPR015645 Peptidase C1A, placentally-expressed cathepsin
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively. In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties.

This entry represents a peptidase inhibitor domain, which belongs to MEROPS peptidase inhibitor family I29. The domain is also found at the N terminus of a variety of peptidase precursors that belong to MEROPS peptidase subfamily C1A; these include cathepsin L, papain, and procaricain (P10056) [1]. It forms an alpha-helical domain that runs through the substrate-binding site, preventing access. Removal of this region by proteolytic cleavage results in activation of the enzyme. This domain is also found, in one or more copies, in a variety of cysteine peptidase inhibitors such as salarin [2].

Structural linksHelp
PDB - click here
SCOP: d.3.1.1
CATH: 3.90.70.10
Database linksHelp
Enzyme: EC:3.4.22
Blocks: IPB013201
MEROPS: C1 , I29

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR013201 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
O60911 Cathepsin L2

O65493 Xylem cysteine proteinase 1

O70370 Cathepsin S

P25777 Oryzain beta chain

Q95029 Cathepsin L

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR013128 Peptidase C1A, papain
IPR000169 Peptidase, cysteine peptidase active site
IPR000668 Peptidase C1A, papain C-terminal
IPR013201 Proteinase inhibitor I29, cathepsin propeptide
IPR000118 Granulin
SWISS-MODEL
PDB Chain
ModBase
SCOP Domain
CATH Domain

PublicationsHelp
1. Groves MR, Taylor MA, Scott M, Cummings NJ, Pickersgill RW, Jenkins JA.
The prosequence of procaricain forms an alpha-helical domain that prevents access to the substrate-binding cleft.
Structure 4 1193-203 1996 [PubMed: 8939744]
http://dx.doi.org/10.1016/S0969-2126(96)00127-X
2. Olonen A, Kalkkinen N, Paulin L.
A new type of cysteine proteinase inhibitor--the salarin gene from Atlantic salmon (Salmo salar L.) and Arctic charr (Salvelinus alpinus).
Biochimie 85 677-81 2003 [PubMed: 14505823]
http://dx.doi.org/10.1016/S0300-9084(03)00128-7

Additional ReadingHelp
Weidauer E, Yasuda Y, Biswal BK, Cherny M, James MN, Bromme D.
Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S.
Biol. Chem. 388 2007 331-6 [PubMed: 17338641]
http://dx.doi.org/10.1515/BC.2007.037
Li Z, Kienetz M, Cherney MM, James MN, Bromme D.
The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex.
J. Mol. Biol. 383 2008 78-91 [PubMed: 18692071]
http://dx.doi.org/10.1016/j.jmb.2008.07.038
Teno N, Miyake T, Ehara T, Irie O, Sakaki J, Ohmori O, Gunji H, Matsuura N, Masuya K, Hitomi Y, Nonomura K, Horiuchi M, Gohda K, Iwasaki A, Umemura I, Tada S, Kometani M, Iwasaki G, Cowan-Jacob SW, Missbach M, Lattmann R, Betschart C.
Novel scaffold for cathepsin K inhibitors.
Bioorg. Med. Chem. Lett. 17 2007 6096-100 [PubMed: 17911019]
http://dx.doi.org/10.1016/j.bmcl.2007.09.047
Inagaki H, Tsuruoka H, Hornsby M, Lesley SA, Spraggon G, Ellman JA.
Characterization and optimization of selective, nonpeptidic inhibitors of cathepsin S with an unprecedented binding mode.
J. Med. Chem. 50 2007 2693-9 [PubMed: 17469812]
http://dx.doi.org/10.1021/jm070111+
Stack CM, Caffrey CR, Donnelly SM, Seshaadri A, Lowther J, Tort JF, Collins PR, Robinson MW, Xu W, McKerrow JH, Craik CS, Geiger SR, Marion R, Brinen LS, Dalton JP.
Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica.
J. Biol. Chem. 283 2008 9896-908 [PubMed: 18160404]
http://dx.doi.org/10.1074/jbc.M708521200
spacer
spacer
InterPro 24.0